Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations.

ABSTRACT:

SUBMITTER: Forbes LR 

PROVIDER: S-EPMC6322659 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature